Cats and Schizophrenia; FDA to Review MDMA PTSD Treatment; Yogurt to Destress?

Owning a cat was linked with more than a 2-times higher risk for developing schizophrenia-related disorders in a meta-analysis. (Schizophrenia Bulletin)

Nearly 60% of adults drink alcohol at least once a month, and more than half do so because it relaxes them, according to a poll from the American Psychiatric Association.

MAPS Public Benefit Corporation said it submitted a new drug application to the FDA for its MDMA-assisted treatment for PTSD, backed by supporting data from the phase III MAPP1 and MAPP2 trials.

A randomized trial involving patients in treatment for opioid use disorder who also had chronic pain demonstrated the benefit of a telehealth mindfulness program atop usual care, with decreased drug use, pain, and depression along with increased adherence to methadone. (JAMA Psychiatry)

Adolescent depression was linked with trait impulsivity in a study of Taiwanese high schoolers. (Psychology Research and Behavior Management)

Intimate partner violence was linked with an increased risk of major depressive disorder and maternal abortion and miscarriage. (Nature Medicine)

Lactobacillus — the bacteria commonly found in yogurt — was protective against environment stress in a mouse model, and could be a potential therapy to treat mood disorders, researchers wrote in Brain, Behavior, and Immunity.

An international expert group released new recommendations on how to improve the development of mental health treatments for young people. (The Lancet Psychiatry)

Former president of the American Psychiatric Association John A. Talbott, MD, of the University of Maryland School of Medicine, passed away at the age of 88. He was best known for his work advocating for the mental care of homeless individuals. (New York Times)

Patients need more care and are presenting with more severe symptoms than in the past, according to an annual survey by the American Psychological Association.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Please enable JavaScript to view the

comments powered by Disqus.